ADVERTISEMENT
AC5 Self-Assembling Peptide: Game-Changing Opportunities for Acute, Chronic, and Challenging Wounds
Live discussion with world-renowned wound care leaders, Terry Treadwell, MD, FACS, and Brock Liden, DPM on the impact AC5 self-assembling peptide technology is having on acute, chronic, and challenging wounds. Utilizing its proprietary adaptive self-assembling peptides and barrier scaffold, AC5 Advanced Wound System continues to provide marked clinical benefit in patients with significant comorbidities and nonhealing wounds. MOA presented by Terry Norchi, MD, CEO of Arch Therapeutics. New case studies will be presented by Dr. Treadwell and Dr. Liden. In addition, two poster presentations, A New Treatment Modality to Expedite Healing in the Case of a Transmetatarsal Breakdown, presented by Jean W. Gillon, MD, and Optimizing the Wound Bed for Application of a Skin Graft with a Novel Adaptive Self-assembling Peptide Barrier Scaffold and a Peptide Technology presented by Thomas Davenport MD, Steven Stavrides, PA, and Jaimee Napolitano, BS, will be on display at SAWC. Representatives from Arch Therapeutics will be available at the event and at booth #831 for additional inquiries.
